Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials

被引：0
|
作者：
Irimia Sieira, P. [1 ]
Torphy, B. [2 ]
Ortega, M. [3 ]
Barash, S. [3 ]
Krasenbaum, L. J. [3 ]
Akcicek, H. [4 ]
Smith, M. [2 ]
Ning, X. [3 ]
Campos, V. Ramirez [3 ]
机构：
[1] Clin Univ Navarra, Neurol Dept, Pamplona, Spain
[2] Chicago Headache Ctr & Res Inst, Chicago, IL USA
[3] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[4] Teva Netherlands BV, Amsterdam, Netherlands
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P035
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    RMD OPEN, 2023, 9 (01):
  • [22] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [23] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
    Shigekazu Kitamura
    Takao Takeshima
    Daishi Yui
    Gabriel Paiva da Silva Lima
    Reija Koukakis
    Cheng Peng
    Ryuji Yoshida
    Yotaro Numachi
    Miki Hasebe
    Neurology and Therapy, 2023, 12 (6) : 1993 - 2006
  • [24] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
    Kitamura, Shigekazu
    Takeshima, Takao
    Yui, Daishi
    Lima, Gabriel Paiva da Silva
    Koukakis, Reija
    Peng, Cheng
    Yoshida, Ryuji
    Numachi, Yotaro
    Hasebe, Miki
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1993 - 2006
  • [25] Impact of Race on the Efficacy and Safety of Tofacitinib in Patients with RA: A Post Hoc Analysis of Phase 2, 3, and 3b/4 Clinical Trials
    Wright, Grace
    Mysler, Eduardo
    Chen, Yi-Hsing
    Kinch, Cassandra
    Yndestad, Arne
    Kwok, Kenneth
    Cadatal, Mary Jane
    Germino, Rebecca
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3495 - 3498
  • [26] Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials
    Mease, Philip
    Kuritzky, Louis
    Wright, Wendy L.
    Mallick-Searle, Theresa
    Fountaine, Robert
    Yang, Ruoyong
    Sadrarhami, Mojgan
    Faison, Warachal
    Johnston, Elizabeth
    Viktrup, Lars
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (11) : 1909 - 1922
  • [27] Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials
    Bihlet, Asger
    Miller, Claire
    Byrjalsen, Inger
    Karsdal, Morten
    Andersen, Jeppe
    Rao, Tharaknath
    Baker, Matthew
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3742 - 3743
  • [28] Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials
    Devinsky, Orrin
    Hyland, Kerry
    Loftus, Rachael
    Nortvedt, Charlotte
    Nabbout, Rima
    EPILEPSY & BEHAVIOR, 2024, 156
  • [29] Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine
    Doty, Erin Gautier
    Krege, John H.
    Jin, Leah
    Raskin, Joel
    Singh, Rashmi B. Halker
    Kalidas, Kavita
    CEPHALALGIA, 2019, 39 (12) : 1569 - 1576
  • [30] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
    Wright, G. C.
    Mysler, E.
    Chen, Y. H.
    Kinch, C.
    Yndestad, A.
    Kwok, K.
    Cadatal, M. J.
    Germino, R.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
12345